GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conmed Corp (NYSE:CNMD) » Definitions » Cyclically Adjusted Price-to-FCF

Conmed (Conmed) Cyclically Adjusted Price-to-FCF : 33.08 (As of May. 22, 2024)


View and export this data going back to 1987. Start your Free Trial

What is Conmed Cyclically Adjusted Price-to-FCF?

As of today (2024-05-22), Conmed's current share price is $75.09. Conmed's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $2.27. Conmed's Cyclically Adjusted Price-to-FCF for today is 33.08.

The historical rank and industry rank for Conmed's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

CNMD' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 18.6   Med: 36.63   Max: 70.84
Current: 32.95

During the past years, Conmed's highest Cyclically Adjusted Price-to-FCF was 70.84. The lowest was 18.60. And the median was 36.63.

CNMD's Cyclically Adjusted Price-to-FCF is ranked better than
58.77% of 228 companies
in the Medical Devices & Instruments industry
Industry Median: 44.93 vs CNMD: 32.95

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Conmed's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $0.866. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $2.27 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Conmed Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Conmed's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conmed Cyclically Adjusted Price-to-FCF Chart

Conmed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.47 52.02 63.24 42.32 49.62

Conmed Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.50 63.89 46.79 49.62 35.24

Competitive Comparison of Conmed's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Conmed's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conmed's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conmed's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Conmed's Cyclically Adjusted Price-to-FCF falls into.



Conmed Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Conmed's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=75.09/2.27
=33.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conmed's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Conmed's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.866/131.7762*131.7762
=0.866

Current CPI (Mar. 2024) = 131.7762.

Conmed Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.119 100.560 0.156
201409 0.398 100.428 0.522
201412 0.810 99.070 1.077
201503 0.386 99.621 0.511
201506 0.234 100.684 0.306
201509 0.357 100.392 0.469
201512 0.311 99.792 0.411
201603 -0.698 100.470 -0.915
201606 0.469 101.688 0.608
201609 0.787 101.861 1.018
201612 0.335 101.863 0.433
201703 0.456 102.862 0.584
201706 0.465 103.349 0.593
201709 0.345 104.136 0.437
201712 0.608 104.011 0.770
201803 0.743 105.290 0.930
201806 0.593 106.317 0.735
201809 -0.004 106.507 -0.005
201812 0.689 105.998 0.857
201903 -0.274 107.251 -0.337
201906 0.566 108.070 0.690
201909 1.065 108.329 1.296
201912 1.159 108.420 1.409
202003 0.030 108.902 0.036
202006 0.063 108.767 0.076
202009 1.082 109.815 1.298
202012 0.527 109.897 0.632
202103 0.613 111.754 0.723
202106 0.964 114.631 1.108
202109 0.491 115.734 0.559
202112 0.933 117.630 1.045
202203 -0.096 121.301 -0.104
202206 0.438 125.017 0.462
202209 0.617 125.227 0.649
202212 -0.567 125.222 -0.597
202303 -0.260 127.348 -0.269
202306 0.696 128.729 0.712
202309 1.285 129.860 1.304
202312 1.636 129.419 1.666
202403 0.866 131.776 0.866

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Conmed  (NYSE:CNMD) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Conmed Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Conmed's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Conmed (Conmed) Business Description

Traded in Other Exchanges
Address
11311 Concept Boulevard, Largo, FL, USA, 33773
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
Executives
Peters Stanley W Iii officer: VP GM General Surgery C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Todd W. Garner officer: Executive Vice President & CFO C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Edward A. Clifford officer: VP Global Manufacturing C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Curt R Hartman director C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
John D. Ferrell officer: Executive Vice President - HR C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Brian Concannon director HAEMONETICS CORP, 400 WOOD RD, BRAINTREE MA 02184-9144
Peter K Shagory officer: EVP,STRAT & CORP DEVT C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Daniel Jonas officer: Vice President/Legal Affairs, other: General Counsel C/O CONMED CORP, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Terence M Berge officer: VP Corp. Treasurer C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Johonna Marie Pelletier officer: Treasurer and VP, Tax C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Jerome J. Lande director 1 WORLD TRADE CENTER, 85TH FLOOR, NEW YORK NY 10007
Brent Lalomia officer: Vice President QA and RA C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
John Jed Kennedy officer: VP GM GI C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Mark E Tryniski director C/O CONMED CORP., 11311 CONCEPT BOULEVARD, LARGO FL 33773
Pat Beyer officer: President-Conmed International C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773